7/28/2015
Researchers reviewed systematic review and meta-analysis to determine whether pregnancy subsequent to successful treatment of melanoma worsens prognosis. | Read More
7/27/2015
Although researchers noted some limitations to this approach, a pilot study found that essential dermatoscopic features leading to accurate diagnosis were visible in 6 of 7 lesions. | Read More
7/24/2015
The disparity between the 2 "safety net" hospitals, both of which serve a disproportionate share of their communities' poorest patients, illustrates a growing divide nationwide. | Read More
7/24/2015
A group of 118 leading cancer experts have developed a list of proposals designed to reduce the cost of cancer drugs. | Read More
7/24/2015
When the merger is complete, the company expects to have an estimated $115 billion in annual revenue and will cover about 53.2 million Americans. | Read More

WEEKLY TOP ARTICLES

7/28/2015

Researchers sought to determine if HIV patients had a greater risk of 30-day hospital readmission compared to those without HIV.

continue reading
7/28/2015

A recent study published in Journal of Endourology compared cost of percutaneous cryoablation to open and robotic partial nephrectomies for similar T1a tumors.

continue reading
7/27/2015

Teva Pharmaceutical Industries has agreed to buy Allergan Plc's generic drugs business for $40.5 billion in a cash and stock deal that will turn the Israeli company into one of the world's largest pharmaceutical firms.

continue reading
7/27/2015

AstraZeneca, under pressure from falling sales of older drugs, is selling a medicine for a rare type of cancer to Sanofi as it continues a drive to raise cash by divesting certain assets.

continue reading
7/27/2015

Two of the most anticipated new heart drugs to be launched in recent years have been priced well above analyst expectations, fuelling the debate about whether modern medicines cost too much.

continue reading
7/27/2015

The FDA approved Praluent for patients with clinical atherosclerotic cardiovascular disease, including those who have had heart attacks or strokes. 

continue reading

Healthcare Reform

The disparity between the 2 "safety net" hospitals, both of which serve a disproportionate share of their communities' poorest patients, illustrates a growing divide nationwide.

View More

When the merger is complete, the company expects to have an estimated $115 billion in annual revenue and will cover about 53.2 million Americans.

View More

While insurance payments may be increasing for certain primary care physicians, some speciality physicians are experiencing the opposite.

View More

Medicare/Medicaid

A slowdown in health care spending has shored up the funding outlook for the federal program that pays elderly Americans' hospital bills.

View More

The CMS proposed fee schedule for 2016 will aim to form payment rates for 2 advance-care planning billing codes to cover complex end-of-life discussions between Medicare patients and their providers.

View More

Health have worked to curb unnecessary use of antibiotics due to overuse, which helped breed superbugs that are harder to treat- particularly for common problems such as UTIs, pneumonia, and bloodstream infections.

View More

Pharmaceutical News

Teva Pharmaceutical Industries has agreed to buy Allergan Plc's generic drugs business for $40.5 billion in a cash and stock deal that will turn the Israeli company into one of the world's largest pharmaceutical firms.

View More

AstraZeneca, under pressure from falling sales of older drugs, is selling a medicine for a rare type of cancer to Sanofi as it continues a drive to raise cash by divesting certain assets.

View More

Two of the most anticipated new heart drugs to be launched in recent years have been priced well above analyst expectations, fuelling the debate about whether modern medicines cost too much.

View More

FDA Activity

The FDA approved Praluent for patients with clinical atherosclerotic cardiovascular disease, including those who have had heart attacks or strokes. 

View More

The FDA approved Novartis AG's oral pill to treat the most common form of advanced skin cancer: basal cell carcinoma.

View More

The PenMate injection device for use with Novo Nordisk's Norditropin Flexpro treatment for growth hormone-related disorders has been approved by the FDA.

View More

Healthcare News

Researchers sought to determine if HIV patients had a greater risk of 30-day hospital readmission compared to those without HIV.

View More

A recent study published in Journal of Endourology compared cost of percutaneous cryoablation to open and robotic partial nephrectomies for similar T1a tumors.

View More

Overall, the computer programs offered accurate triage advice for 57 percent of the standardized scenarios that were used in the researchers’ tests.

View More

Guideline Updates

New guidelines for prescribing cholesterol-lowering medications are efficient and cost-effective, according to two new studies.

View More

About 400,000 more young people ages 17 to 21 with high LDL cholesterol would be treated with statins under pediatric guidelines as opposed to adult guidelines.

View More

The American Heart Association, American College of Cardiology, and American Society of Hypertension update guideline recommendations.

View More
The $2.8 trillion US healthcare industry is undergoing a dramatic transformation. continue reading
MS is characterized by CNS inflammation, demyelination, axonal injury, and axonal loss. Lesions of the CNS white matter, with loss of myelin, neuronal axons, and myelin-producing oligodenrocytes, characterize MS physiopathology. continue reading